2 ms·
Not really sure why this matters in the case of insulin - the "good" modern-day insulins will never fall into generics because the companies have a backlog of i
by sithlord 8y ago
Not really sure why this matters in the case of insulin - the "good" modern-day insulins will never fall into generics because the companies have a backlog of incremental changes they hold on to until they need to renew a patent.
- majewsky 8y agoThat agrees with mikl's claim that "you can thank [...] the patent system [...] for that".